# Spinal Muscular Atrophy treatment challenges in Brazil

> Live situation record from CLSTR: https://clstr.news/situations/spinal-muscular-atrophy-treatment-challenges-in-brazil
> Updated: 2026-08-09T00:56:21.000Z. Sources: 8. Developments: 2.

In Brazil, challenges regarding the treatment of Spinal Muscular Atrophy (SMA) have emerged, involving both logistical delays and the high costs of gene therapy. While the public health system (SUS) offers the Zolgensma gene therapy free of charge to eligible infants, the medication's high cost has prompted local community fundraising efforts for individual patients facing strict treatment deadlines.

Broader systemic issues persist as health experts warn that delays in diagnosis and treatment are leading to irreversible motor function loss. Data indicates that while SMA Type 1 is diagnosed on average at five months of age, patients face an average wait time of 1.7 years for treatment, significantly longer than in other countries. These delays are attributed to bottlenecks in the implementation of Law No. 14.154/2021, which was intended to expand neonatal screening programs.

## Timeline

### 2026-08-09: SMA diagnosis delays in Brazil cause irreversible motor loss

Delays in diagnosing Spinal Muscular Atrophy (SMA) in Brazil are causing irreversible motor loss, as the implementation of expanded neonatal screening via the SUS remains slow across most states.

8 sources. https://clstr.news/cluster/sma-diagnosis-delays-in-brazil-cause-irreversible-motor-loss

### 2026-07-20: Zolgensma gene therapy provides lifesaving option for Brazilian SMA patients

Zolgensma, a costly gene‑therapy for SMA, is free for infants in Brazil’s SUS but still requires fundraising for a boy in Rio Grande do Sul who must receive it before age two.

2 sources. https://clstr.news/cluster/zolgensma-gene-therapy-provides-lifesaving-option-for-brazilian-sma-patients

---
Cite as: Spinal Muscular Atrophy treatment challenges in Brazil. CLSTR, https://clstr.news/situations/spinal-muscular-atrophy-treatment-challenges-in-brazil
